Sign In
Buy AMGN
$338.22
+9.96 (+3.03%)
At Close: Jun 03, 2026
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:00am, Friday, 05'th Dec 2025
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Baird Financial Group Inc. Cuts Position in Amgen Inc. $AMGN
05:16am, Friday, 05'th Dec 2025
Baird Financial Group Inc. reduced its stake in shares of Amgen Inc. (NASDAQ: AMGN) by 8.0% during the undefined quarter, according to its most recent 13F filing with the SEC. The institutional invest
Beutel Goodman & Co Ltd. Raises Position in Amgen Inc. $AMGN
05:16am, Friday, 05'th Dec 2025
Beutel Goodman and Co Ltd. boosted its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 2.7% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,436
Why Is Amgen (AMGN) Up 8% Since Last Earnings Report?
12:30pm, Thursday, 04'th Dec 2025
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?
3 Potential Mid-Cap Biotech Buyout Targets In 2026
06:22pm, Wednesday, 03'rd Dec 2025
The biotech sector began December with notable weakness, as both IBB and XBI ETFs declined over two percent during trading on Monday. The sector has bounced back since. However, small biotech stocks
Amgen Inc. (AMGN) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
05:23pm, Wednesday, 03'rd Dec 2025
Amgen Inc. (AMGN) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Amgen Inc. (AMGN) Presents at Evercore 8th Annual Healthcare Conference Transcript
05:13pm, Wednesday, 03'rd Dec 2025
Amgen Inc. (AMGN) Presents at Evercore 8th Annual Healthcare Conference Transcript
Analyst Says Viridian's New Thyroid Eye Drug Could Outperform Amgen's Tepezza
03:25pm, Wednesday, 03'rd Dec 2025
William Blair starts coverage of Viridian, citing veligrotug's advantages over Tepezza and key 2026 catalysts, including FDA review and VRDN-003 Phase 3 data.
30% of the S&P 500 Is Mag 7 Tech Stocks, but This ETF Refuses to Own a Single One
08:51am, Tuesday, 02'nd Dec 2025
The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.
Beacon Pointe Advisors LLC Sells 4,768 Shares of Amgen Inc. $AMGN
04:14am, Tuesday, 02'nd Dec 2025
Beacon Pointe Advisors LLC trimmed its position in Amgen Inc. (NASDAQ: AMGN) by 5.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exch
2 Dividend Stocks to Double Up On Right Now
11:37pm, Monday, 01'st Dec 2025
Coca-Cola is showing why it has increased its dividend for 63 consecutive years. Amgen should maintain its strong dividend program despite some patent cliffs.
AMGN Up Almost 16% in a Month: Should You Buy, Sell or Hold the Stock?
12:01pm, Monday, 01'st Dec 2025
Amgen's nearly 16% surge follows strong Q3 results, raised sales guidance and growing momentum across key drugs and biosimilars.
Boston Family Office LLC Boosts Stake in Amgen Inc. $AMGN
03:32am, Monday, 01'st Dec 2025
Boston Family Office LLC boosted its holdings in Amgen Inc. (NASDAQ: AMGN) by 13.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The
Berry Wealth Group LP Buys New Holdings in Amgen Inc. $AMGN
04:38am, Saturday, 29'th Nov 2025
Berry Wealth Group LP bought a new position in shares of Amgen Inc. (NASDAQ: AMGN) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The i
American Century Companies Inc. Has $46.10 Million Stock Position in Amgen Inc. $AMGN
03:19am, Saturday, 29'th Nov 2025
American Century Companies Inc. boosted its holdings in shares of Amgen Inc. (NASDAQ: AMGN) by 110.9% during the second quarter, according to the company in its most recent Form 13F filing with the Se
